Jaw Reduction, TL / Timor-Leste

Jaw Reduction, TL / Timor-Leste @beautytl_com: Botox® Cosmetic, Dysport®, BTX-A, botulinum toxin type A injection, wrinkle removal treatment clinic, TL / Timor-Leste. Cost/price for treating glabella frown lines, crow's feet, and horizontal forehead lines. Definitions, references, and latest news.

Description

Botox® is one of the trade names for botulinum toxin, which is a protein produced by the bacterium clostridium botulinum.

Botox® price. Average Botox® cost.

Jaw reduction / jaw slimming / face slimming / Botox® jaw reduction / Botox® jaw slimming / Botox® face slimming price.

Botox® treatment is with the original Allergan Botox® Cosmetic

• The units differ for different brands.
• Price quoted is for average ladies face, with average musculature.
• Muscular men might require up to twice as much.
• Minimum charge is for 10 units.

Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:

SHIM CLINIC 168 Bedok South Avenue 3 #01-473 Singapore 460168 Tel: (+65) 6100 7446 Fax: (+65) 6449 7446 24hr Answering Tel: (+65) 6333 5550 Web: Jaw Reduction, TL / Timor-Leste

Opening Hours Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm Saturday & Sunday: 7 pm to 11 pm Public Holidays: Closed Last registration: half hour before closing time. Walk-in clinic. Appointments not required. Bring NRIC, Work Pass or Passport for registration.

References

• Botox - Wikipedia, the free encyclopedia
• Botox: Definition from Answers.com

Books: Gauging Faces and Bodies in the Botox Age
Mon, 25 Feb 2013 22:27:01 +0100 | NYT Health
Despite centuries’ worth of efforts to penetrate the complicated thickets where health and beauty intertwine, there is always more to explore, as two new books make clear. (Source: NYT Health)

Clues Found for Disparity in Botox Facial Dose (CME/CE)
Sat, 23 Feb 2013 00:43:06 +0100 | MedPage Today Dermatology
(MedPage Today) -- Upper facial muscles require substantially greater paralysis than lower facial muscles to achieve the desired aesthetic appearance in patients with wrinkles, necessitating higher doses of onabotulinum toxin A, a study suggested. (Source: MedPage Today Dermatology)

Managing and Treating Tension-type Headache.
Thu, 21 Feb 2013 00:00:03 +0100 | The Medical Clinics of North America
Authors: Freitag F

As Economy Rebounds, More Folks Try Turning Back Hands of Time
Tue, 19 Feb 2013 21:00:00 +0100 | MedlinePlus Health News
Report on cosmetic procedures finds Botox, fillers, chemical peels and laser hair removal topped the list last year

Demand for Botox, fillers drives U.S. cosmetic surgery growth
Tue, 19 Feb 2013 19:13:41 +0100 | Reuters: Health
NEW YORK (Reuters) - Botox, fillers and chemical peels were among the most popular cosmetic treatments in the United States and fueled growth in the plastic surgery industry for the third consecutive year, according to statistics released on Tuesday. (Source: Reuters: Health)

Safety of Onabotulinum Toxin A for the Treatment of Chronic Post-Traumatic Headache in Service Members with a History of Mild Traumatic Brain Injury (P01.076)
Thu, 14 Feb 2013 05:00:00 +0100 | Neurology
CONCLUSIONS: OBA appears to be safe and well tolerated in active duty service members treated for PTH, warranting further studies of efficacy and consistency of effect.Disclosure: Dr. Yerry has nothing to disclose. Dr. Lewis has nothing to disclose. Dr. Finkel has recieved personal compensation for activities with Allergan as a consultant. (Source: Neurology)

Serum False Positive Botulism in a Case with Miller Ficher Syndrome (P01.120)
Thu, 14 Feb 2013 05:00:00 +0100 | Neurology
CONCLUSIONS: These findings might suggest either a role of the Anti GQ1b antibodies or antibodies found in MFS to be toxic to mouse. Above can also mean similar site of actions of the antibodies or suggest possible cross reactivity of the antibodies with botulinum toxin. If this true than we might be able to imply that there is a possible role of botulinum toxin in treatment or management of MFS or vice versa.Disclosure: Dr. Zeylikman has nothing to disclose. Dr. Campellone has received personal compensation for activities with Allergan, Inc. and Teva Neuroscience. Dr. Mirsen has nothing to disclose. (Source: Neurology)

Onabotulium Toxin Type A (Botox@) in the Treatment of Chronic Post Traumatic Headache Related to Sports Concussion: A Case Report (P01.269)
Thu, 14 Feb 2013 05:00:00 +0100 | Neurology
CONCLUSIONS: Onabotulinum Toxin Type A may be an effective treatment in very carefully selected concussed athletes with prolonged headache symptoms. Further research into proper patient selection, long term outcome, return to play and risk of future concussion are needed.Disclosure: Dr. Conidi has received personal compensation for activities with Allergan, Inc. and Forest. Dr. Conidi has received research support from Allergan, Inc. (Source: Neurology)

Loss of Brainstem Auditory Evoked Potentials during Microvascular Decompression For Hemifacial Spasm (P03.054)
Thu, 14 Feb 2013 05:00:00 +0100 | Neurology
CONCLUSIONS: Preoperative use of botox injection was significantly higher in patients with loss of wave V during MVD. Though one fourth of the patients lost wave V more than half of them had some improvement during MVD. Some patients had no HL despite wave V loss, among them more than half had transient loss of wave V. Appropriate alarm criteria needs to be developed to warn the surgeon about an impending loss of wave V during MVD.Disclosure: Dr. Krishnaiah has nothing to disclose. Dr. Thirumala has nothing to disclose. Dr. Habeych has nothing to disclose. Dr. Crammond has nothing to disclose. Dr. Balzer has nothing to disclose. (Source: Neurology)

OnabotulinumtoxinA Efficacy in Lower Limb Spasticity: Results of Three Studies (P03.264)
Thu, 14 Feb 2013 05:00:00 +0100 | Neurology
CONCLUSIONS: OnabotulinumtoxinA (300U) significantly decreases ankle flexor tone in adults with post-stroke lower-limb spasticity.Supported by: Allergan, Inc.Disclosure: Dr. Dimitrova has received personal compensation for activities with Allergan, Inc. as an employee. Consulting service from Glaxo-Smith-Kline, Japan.....Financial support from GSK Japan, Eisai Dr. Kaji has received personal compensatino for activities with Glaxo-Smith-Kline, Japan as a consultant. Dr. Kaji has received research support from GSK Japan, Eisai. Dr. Ward has received personal compensation for activities with Allergan Inc. as a participant on an advisory board. Dr. Ward has received research support from Allergan Inc. Dr. Li has received personal compensation for activities with Allergan, Inc as an employee. Dr...